Diagnostics for personalized medicine: what will change in the era of large-scale genomics studies?

Personalized Medicine
Anoop Grewal, Dietrich A Stephan

Abstract

The era of personalized medicine is upon us and it is being fueled by large available data sets of many types that are setting the foundation for the development of more precise diagnostic tools and targeted therapies, which are improving patient outcomes. Technology innovation and concomitant price decreases in molecular scanning technologies are at the heart of this change, both accelerating at a rate that has exceeded Moore's law. This technology trend is enabling the research community to generate, and make publicly available, massive amounts of genomic data. These data come in the form not only of contextual information about the structure and function of the genome, but also in the form of variants that are correlated with human disease. Coupled with this molecular information, we are making dramatic inroads into capturing and making available high-resolution phenotypic and environmental exposure data through both incentives to physicians to migrate electronic medical records and to adoption of consumer-facing data collection and aggregation technologies. These large-scale genomic, environmental and phenotypic data together allow us to provide a multitude of new diagnostic correlations across the spectrum of possible clin...Continue Reading

References

Mar 1, 1997·Trends in Genetics : TIG·M Krawczak, D N Cooper
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Feb 9, 2000·JAMA : the Journal of the American Medical Association·D SchragJ C Weeks
Jan 11, 2000·Nucleic Acids Research·S T SherryK Sirotkin
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Nov 21, 2001·Genetics in Medicine : Official Journal of the American College of Medical Genetics·P W YoonM J Khoury
Dec 26, 2001·Nucleic Acids Research·Ron EdgarAlex E Lash
Oct 25, 2003·Science·Jennifer Couzin
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
May 28, 2004·Nature·Christopher S CarlsonDeborah A Nickerson
Mar 12, 2005·Science·Jonathan L HainesMargaret A Pericak-Vance
Mar 12, 2005·Science·Albert O EdwardsLindsay A Farrer
Mar 12, 2005·Science·Robert J KleinJosephine Hoh
Aug 5, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Diane Hu-LinceDietrich A Stephan
Oct 28, 2005·American Journal of Human Genetics·Demetrius M MaraganoreDennis G Ballinger
Dec 29, 2005·American Journal of Human Genetics·Nilesh J SamaniUNKNOWN BHF Family Heart Study Research Group
Jul 11, 2006·Breast Disease·James P EvansMegan Harlan
Oct 21, 2006·Science·Andreas PapassotiropoulosDominique J-F de Quervain
Aug 3, 2007·The New England Journal of Medicine·Travis DunckleyDietrich A Stephan
Dec 6, 2007·Journal of General Internal Medicine·Christine VogeliDavid Blumenthal
Jan 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Susan J GrossUNKNOWN Professional Practice and Guidelines Committee
Sep 17, 2008·Nature Methods·David W CraigMatthew J Huentelman
Nov 18, 2008·The Lancet Oncology·Dominique Levêque
Jan 28, 2009·Behavioral Neuroscience·Matthew J HuentelmanHeather A Bimonte-Nelson
Mar 10, 2009·Nature Biotechnology·Eran Halperin, Dietrich A Stephan
Apr 9, 2009·Nature Biotechnology·Eran Halperin, Dietrich A Stephan
Mar 2, 2010·Journal of the American Medical Informatics Association : JAMIA·Shawn N MurphyIsaac Kohane
Sep 3, 2010·Nature·UNKNOWN International HapMap 3 ConsortiumJean E McEwen
Jan 11, 2011·PloS One·Badri PadhukasahasramDietrich A Stephan
Jan 14, 2011·Science Translational Medicine·Callum J BellStephen F Kingsmore
Jul 12, 2011·Molecular & Cellular Proteomics : MCP·Pierre LegrainGilbert S Omenn
Sep 17, 2011·Genome Biology·Christian GilissenJoris A Veltman
Sep 8, 2012·Nature·UNKNOWN ENCODE Project Consortium
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Nov 10, 2012·Nature Biotechnology·Eugene FratkinDietrich A Stephan
Apr 9, 2013·Nature Biotechnology·James BrownPeter Turnbaugh
May 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amandine EverardPatrice D Cani

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
xenograft
genotyping
biopsies
exome sequencing

Software Mentioned

ClinVar
HealthVault
GeneInsight
BEAUTY
Polymorphism Phenotyping ( Polyphen - 2 )
Google Health
Indivo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.